Lanean...
Targeted drug delivery using iRGD peptide for solid cancer treatment
Many solid tumor types, such as pancreatic cancer, have a generally poor prognosis, in part because the delivery of therapeutic regimen is prohibited by pathological abnormalities that block access to tumor vasculature, leading to poor bioavailability. Recent development of tumor penetrating iRGD pe...
Gorde:
| Argitaratua izan da: | Mol Syst Des Eng |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6258069/ https://ncbi.nlm.nih.gov/pubmed/30498580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/C7ME00050B |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|